BCART — Biocartis NV Share News
0.000.00%
Last trade - 00:00HealthcareBalancedMicro Cap
Brief: Biocartis Appoints New Chief Business Officer, VP Global Marketing
Brief: Biocartis And Merck To Collaborate
Brief: Biocartis's Secured Creditors Enforced Their Security Over Subsidiaries Shares
Brief: Biocartis Announces Expansion Of Its Collaboration With Apis Assay Technologies
Brief: Biocartis H1 Product-Related Revenue Up At EUR 23.5 Mln
Brief: Biocartis Announces Agreement Regarding Recapitalization Of Operating Subsidiaries By Secured Creditors
Brief: Biocartis H1 Net Income at EUR -31.3 Million
Brief: Biocartis Partners With Lilly On Biomarker Testing For NSCLC Patients Using Idylla Platform
Brief: Biocartis Appoints George Cardoza As New CFO
Brief: Biocartis Group Withdraws 2023 Outlook
Brief: Biocartis Group's CFO Resigns
Brief: Biocartis To Partner With Hiloprobe On Colorectal Cancer Test
Brief: Biocartis Group Q1 EBITDA Loss Of EUR 8.4 Mln
Persbericht Biocartis Group NV: Biocartis rapporteert resultaten eerste kwartaal 2023
Press release Biocartis Group NV: Biocartis Reports Results of First Quarter of 2023
Brief: Biocartis Appoints Roger Moody As New CEO
Brief: Biocartis And Apis Assay Technologies Sign Collaboration To Develop Breast Cancer Subtyping Test
Brief: Biocartis Announces FDA Clearance For Idylla MSI Test
Brief: Biocartis Creates New Share Option Plan